Viewing Study NCT03344094


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-01-04 @ 1:15 AM
Study NCT ID: NCT03344094
Status: COMPLETED
Last Update Posted: 2025-02-21
First Post: 2017-10-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Mechanism of Action of Ocrelizumab in Multiple Sclerosis
Sponsor: University of Chicago
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-02-23
Start Date Type: ACTUAL
Primary Completion Date: 2019-04-10
Primary Completion Date Type: ACTUAL
Completion Date: 2019-04-10
Completion Date Type: ACTUAL
First Submit Date: 2017-10-13
First Submit QC Date: None
Study First Post Date: 2017-11-17
Study First Post Date Type: ACTUAL
Results First Submit Date: 2020-11-04
Results First Submit QC Date: None
Results First Post Date: 2025-02-21
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-02-03
Last Update Post Date: 2025-02-21
Last Update Post Date Type: ACTUAL